Tags |
|
|
Links |
|
|
Useful Advices - Downsizing Your Team
Team Building Question:
Our office has recently learned
Our office has recently learned
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
that about 20 percent of our staff will be losing their j
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
bs in the next couple of months due to a relocation set d
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
wn from our corporate office. Some open positions in my a
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
rea are being posted for those losing their jobs. The mor
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
le in the workplace is really down right now, plus we are
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
dealing with some disciplinary issues. I would be very op
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
en to any suggestions as to how to make this a smooth tra
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
sition and boost morale.
The Team Doc Says:
There is ve
The Team Doc Says:
There is ve
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
y little you can do to control how people feel about this
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
situation. And the survivors will probably feel the worst
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
.
That said, there may be legal issues that must remain
That said, there may be legal issues that must remain
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
uiet, but now is the time for as much communication as po
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
sible. Even if the answer is “I don’t know” or “For legal
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
reasons I can’t tell you that.” Have regular get togethe
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s with your team to talk about what is going on.
You’ll
You’ll
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
e able to tell whether you are communicating enough by li
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
stening to the noise level at your company. Is the rumor
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ill really loud or just a soft murmur? The louder the rum
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
r mill, the more you need to communicate to quiet it down
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/45889/usefuladvices-Downsizing-Your-Team.html">Downsizing Your Team</a>
BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/45889/usefuladvices-Downsizing-Your-Team.html]Downsizing Your Team[/url]
Related Articles:
Analytic Business Intelligence: Is it same as Business Intelligence?
Are Articles Needed for Google Adsense Cash
Interactive Dashboard on Sage SalesLogix v7 – More of What You Need At a Glance
Bookmark it:
|